Arcellx, Inc. Files 8-K: Director/Officer Changes & More

Ticker: ACLX · Form: 8-K · Filed: Mar 20, 2025 · CIK: 1786205

Arcellx, INC. 8-K Filing Summary
FieldDetail
CompanyArcellx, INC. (ACLX)
Form Type8-K
Filed DateMar 20, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: director-changes, officer-appointment, compensatory-arrangements

TL;DR

Arcellx 8-K: Director/officer shakeup, new comp plans filed. Watch closely.

AI Summary

Arcellx, Inc. filed an 8-K on March 20, 2025, reporting events as of March 17, 2025. The filing indicates changes related to the departure and election of directors, appointment of officers, and compensatory arrangements. It also includes Regulation FD disclosures and financial statements/exhibits.

Why It Matters

This filing signals potential shifts in the company's leadership and governance structure, which could impact strategic direction and investor confidence.

Risk Assessment

Risk Level: medium — Changes in directors and officers, along with compensatory arrangements, can indicate internal shifts that may affect company strategy and performance.

Key Numbers

Key Players & Entities

FAQ

What specific changes were made regarding directors or officers?

The filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers.

What is the date of the earliest event reported in this 8-K?

The earliest event reported is dated March 17, 2025.

What are the main items covered in this 8-K filing?

The filing covers departure/election of directors, appointment of officers, compensatory arrangements, Regulation FD disclosures, and financial statements/exhibits.

Where is Arcellx, Inc. headquartered?

Arcellx, Inc.'s principal executive offices are located at 800 Bridge Parkway, Redwood City, CA 94065.

What is the company's SIC code?

The company's Standard Industrial Classification (SIC) code is 2836, for BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 20, 2025 regarding Arcellx, Inc. (ACLX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing